Annual Total Expenses
$13.32 M
-$6.39 M-32.42%
01 December 2023
Summary:
Plus Therapeutics annual total expenses is currently $13.32 million, with the most recent change of -$6.39 million (-32.42%) on 01 December 2023. During the last 3 years, it has risen by +$3.43 million (+34.73%). PSTV annual total expenses is now -70.75% below its all-time high of $45.54 million, reached on 31 December 2013.PSTV Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$3.80 M
+$102.00 K+2.76%
01 September 2024
Summary:
Plus Therapeutics quarterly total expenses is currently $3.80 million, with the most recent change of +$102.00 thousand (+2.76%) on 01 September 2024. Over the past year, it has dropped by -$59.00 thousand (-1.53%). PSTV quarterly total expenses is now -69.79% below its all-time high of $12.58 million, reached on 31 December 2013.PSTV Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -1.5% |
| 3 y3 years | +34.7% | +9.1% |
| 5 y5 years | +13.4% | +81.7% |
PSTV Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.4% | +34.7% | -31.8% | +155.0% |
| 5 y | 5 years | -32.4% | +34.7% | -31.8% | +172.1% |
| alltime | all time | -70.8% | +547.6% | -69.8% | +172.1% |
Plus Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.80 M(+2.8%) |
| June 2024 | - | $3.70 M(+12.1%) |
| Mar 2024 | - | $3.30 M(-14.5%) |
| Dec 2023 | $13.32 M(-32.4%) | $3.86 M(+18.7%) |
| Sept 2023 | - | $3.25 M(+118.2%) |
| June 2023 | - | $1.49 M(-68.4%) |
| Mar 2023 | - | $4.72 M(-15.3%) |
| Dec 2022 | $19.71 M(+58.6%) | $5.57 M(+9.4%) |
| Sept 2022 | - | $5.09 M(-0.5%) |
| June 2022 | - | $5.12 M(+30.4%) |
| Mar 2022 | - | $3.93 M(+0.9%) |
| Dec 2021 | $12.43 M(+25.7%) | $3.89 M(+11.8%) |
| Sept 2021 | - | $3.48 M(+35.2%) |
| June 2021 | - | $2.58 M(+3.9%) |
| Mar 2021 | - | $2.48 M(-27.0%) |
| Dec 2020 | $9.89 M(-7.2%) | $3.40 M(+143.2%) |
| Sept 2020 | - | $1.40 M(-45.0%) |
| June 2020 | - | $2.54 M(-0.9%) |
| Mar 2020 | - | $2.56 M(-24.8%) |
| Dec 2019 | $10.65 M(-9.3%) | $3.40 M(+62.6%) |
| Sept 2019 | - | $2.09 M(+6.7%) |
| June 2019 | - | $1.96 M(-32.5%) |
| Mar 2019 | - | $2.90 M(-40.7%) |
| Dec 2018 | $11.74 M(-56.7%) | $4.89 M(+119.7%) |
| Sept 2018 | - | $2.23 M(-51.3%) |
| June 2018 | - | $4.58 M(-23.8%) |
| Mar 2018 | - | $6.00 M(+16.3%) |
| Dec 2017 | $27.09 M(-12.8%) | $5.16 M(-15.7%) |
| Sept 2017 | - | $6.12 M(-13.6%) |
| June 2017 | - | $7.08 M(-19.0%) |
| Mar 2017 | - | $8.74 M(+32.1%) |
| Dec 2016 | $31.09 M(-10.2%) | $6.62 M(-10.7%) |
| Sept 2016 | - | $7.41 M(-18.1%) |
| June 2016 | - | $9.05 M(+12.9%) |
| Mar 2016 | - | $8.02 M(-1.5%) |
| Dec 2015 | $34.61 M(-14.3%) | $8.13 M(+4.4%) |
| Sept 2015 | - | $7.79 M(-27.8%) |
| June 2015 | - | $10.79 M(+36.6%) |
| Mar 2015 | - | $7.90 M(-5.1%) |
| Dec 2014 | $40.40 M(-11.3%) | $8.32 M(-8.8%) |
| Sept 2014 | - | $9.13 M(-23.8%) |
| June 2014 | - | $11.98 M(+9.1%) |
| Mar 2014 | - | $10.98 M(-12.7%) |
| Dec 2013 | $45.54 M(+6.4%) | $12.58 M(+12.6%) |
| Sept 2013 | - | $11.17 M(-0.4%) |
| June 2013 | - | $11.21 M(+6.0%) |
| Mar 2013 | - | $10.58 M(-9.5%) |
| Dec 2012 | $42.79 M | $11.69 M(+11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $10.48 M(-1.3%) |
| June 2012 | - | $10.63 M(+6.4%) |
| Mar 2012 | - | $9.99 M(+6.3%) |
| Dec 2011 | $43.03 M(+15.7%) | $9.40 M(-14.0%) |
| Sept 2011 | - | $10.93 M(-9.3%) |
| June 2011 | - | $12.04 M(+13.0%) |
| Mar 2011 | - | $10.66 M(-14.1%) |
| Dec 2010 | $37.20 M(+2.6%) | $12.40 M(+11.0%) |
| Sept 2010 | - | $11.18 M(+56.5%) |
| June 2010 | - | $7.14 M(+10.1%) |
| Mar 2010 | - | $6.49 M(-45.8%) |
| Dec 2009 | $36.28 M(-0.9%) | $11.97 M(+53.3%) |
| Sept 2009 | - | $7.81 M(-12.9%) |
| June 2009 | - | $8.97 M(+19.2%) |
| Mar 2009 | - | $7.52 M(-10.5%) |
| Dec 2008 | $36.61 M(+13.9%) | $8.40 M(-14.0%) |
| Sept 2008 | - | $9.78 M(+0.0%) |
| June 2008 | - | $9.78 M(+15.3%) |
| Mar 2008 | - | $8.48 M(-21.6%) |
| Dec 2007 | $32.14 M(+17.7%) | $10.81 M(+20.4%) |
| Sept 2007 | - | $8.98 M(+35.5%) |
| June 2007 | - | $6.63 M(-27.1%) |
| Mar 2007 | - | $9.09 M(+280.9%) |
| Dec 2006 | $27.31 M(-18.8%) | $2.39 M(-73.5%) |
| Sept 2006 | - | $9.00 M(+14.3%) |
| June 2006 | - | $7.88 M(-2.0%) |
| Mar 2006 | - | $8.04 M(-26.7%) |
| Dec 2005 | $33.63 M(+51.0%) | $10.97 M(+16.1%) |
| Sept 2005 | - | $9.45 M(+37.1%) |
| June 2005 | - | $6.89 M(+9.7%) |
| Mar 2005 | - | $6.28 M(+19.1%) |
| Dec 2004 | $22.28 M(-4.4%) | $5.28 M(-13.5%) |
| Sept 2004 | - | $6.10 M(+15.3%) |
| June 2004 | - | $5.29 M(-9.7%) |
| Mar 2004 | - | $5.86 M(-2.0%) |
| Dec 2003 | $23.30 M(+12.7%) | $5.97 M(-13.7%) |
| Sept 2003 | - | $6.92 M(+36.7%) |
| June 2003 | - | $5.06 M(-5.3%) |
| Mar 2003 | - | $5.35 M(-4.7%) |
| Dec 2002 | $20.67 M(+21.0%) | $5.61 M(-10.1%) |
| Sept 2002 | - | $6.24 M(+37.9%) |
| June 2002 | - | $4.53 M(+5.5%) |
| Mar 2002 | - | $4.29 M(+51.0%) |
| Dec 2001 | $17.08 M(+7.7%) | $2.84 M(-38.3%) |
| Sept 2001 | - | $4.60 M(-19.4%) |
| June 2001 | - | $5.71 M |
| Dec 2000 | $15.86 M(+164.9%) | - |
| Dec 1999 | $5.99 M(+191.1%) | - |
| Dec 1998 | $2.06 M | - |
FAQ
- What is Plus Therapeutics annual total expenses?
- What is the all time high annual total expenses for Plus Therapeutics?
- What is Plus Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Plus Therapeutics?
- What is Plus Therapeutics quarterly total expenses year-on-year change?
What is Plus Therapeutics annual total expenses?
The current annual total expenses of PSTV is $13.32 M
What is the all time high annual total expenses for Plus Therapeutics?
Plus Therapeutics all-time high annual total expenses is $45.54 M
What is Plus Therapeutics quarterly total expenses?
The current quarterly total expenses of PSTV is $3.80 M
What is the all time high quarterly total expenses for Plus Therapeutics?
Plus Therapeutics all-time high quarterly total expenses is $12.58 M
What is Plus Therapeutics quarterly total expenses year-on-year change?
Over the past year, PSTV quarterly total expenses has changed by -$59.00 K (-1.53%)